Literature DB >> 30020019

Implementation and assessment of vaccination programmes: the importance of vaccination sequence for overall health outcomes.

Ane Bærent Fisker1,2,3, Sanne Marie Thysen1,2,4.   

Abstract

In addition to their effect on the target infections, accumulating evidence indicates that vaccines have non-specific effects. Live measles vaccine (MV) has beneficial NSEs reducing mortality by more than can be explained by preventing measles infection. In contrast, non-live diphtheria-tetanus-pertussis vaccine (DTP) has negative NSEs; in spite of protecting against diphtheria, tetanus and pertussis, it is associated with increased mortality. The most recent vaccine has the strongest effect on child health, and therefore sequence of vaccines is important. There is consistent evidence that DTP with or after MV is associated with increased mortality compared with having MV as the most recent vaccine, but the sequence of vaccines is not considered in the current evaluation and implementation of vaccination programmes. To maximise the impact of current vaccination programmes on child health, increased emphasis should be placed on receiving MV after DTP. Increasing time with live MV as the most recent vaccine through better adherence to the schedule, and modified recommendations for catch-up vaccinations for children who do not follow the recommended schedule are likely to result in improvements in child health.

Entities:  

Keywords:  Non-specific effects of vaccines; child mortality; expanded programme on immunizations; heterologous immunity

Year:  2018        PMID: 30020019      PMCID: PMC6343624          DOI: 10.1080/21645515.2018.1496771

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  12 in total

Review 1.  A small jab - a big effect: nonspecific immunomodulation by vaccines.

Authors:  Christine S Benn; Mihai G Netea; Liisa K Selin; Peter Aaby
Journal:  Trends Immunol       Date:  2013-05-14       Impact factor: 16.687

2.  A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.

Authors:  Ane B Fisker; Eric Nebie; Anja Schoeps; Cesario Martins; Amabelia Rodrigues; Alphonse Zakane; Moubassira Kagone; Stine Byberg; Sanne M Thysen; Justin Tiendrebeogo; Boubacar Coulibaly; Osman Sankoh; Heiko Becher; Hilton C Whittle; Fiona R M van der Klis; Christine S Benn; Ali Sie; Olaf Müller; Peter Aaby
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

3.  Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana.

Authors:  Paul Welaga; Abraham Oduro; Cornelius Debpuur; Peter Aaby; Henrik Ravn; Andreas Andersen; Fred Binka; Abraham Hodgson
Journal:  Vaccine       Date:  2017-03-22       Impact factor: 3.641

4.  Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country.

Authors:  Sidu Biai; Amabelia Rodrigues; Jens Nielsen; Morten Sodemann; Peter Aaby
Journal:  Vaccine       Date:  2011-04-06       Impact factor: 3.641

5.  Risk of Nontargeted Infectious Disease Hospitalizations Among US Children Following Inactivated and Live Vaccines, 2005-2014.

Authors:  Barbara H Bardenheier; Michael M McNeil; A Patricia Wodi; Janet M McNicholl; Frank DeStefano
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

6.  Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.

Authors:  Peter Aaby; Henrik Jensen; Badara Samb; Badara Cisse; Morten Sodemann; Marianne Jakobsen; Anja Poulsen; Amabelia Rodrigues; Ida Maria Lisse; Francois Simondon; Hilton Whittle
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

7.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

8.  Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau.

Authors:  J Agergaard; E Nante; G Poulstrup; J Nielsen; K L Flanagan; L Østergaard; C S Benn; P Aaby
Journal:  Vaccine       Date:  2010-11-18       Impact factor: 3.641

Review 9.  Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.

Authors:  Julian P T Higgins; Karla Soares-Weiser; José A López-López; Artemisia Kakourou; Katherine Chaplin; Hannah Christensen; Natasha K Martin; Jonathan A C Sterne; Arthur L Reingold
Journal:  BMJ       Date:  2016-10-13

10.  Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.

Authors:  Peter Aaby; Andreas Andersen; Cesário L Martins; Ane B Fisker; Amabelia Rodrigues; Hilton C Whittle; Christine S Benn
Journal:  BMJ Open       Date:  2016-12-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.